eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 02/02/2012
PIL Synagis 100mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 27/05/2010 and displayed until 02/02/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 17/12/2009 and displayed until 27/05/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
  • Change to side-effects
  • Change to MA holder contact details
Updated on 10/12/2008 and displayed until 17/12/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 13/11/2006 and displayed until 10/12/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 07/11/2006 and displayed until 13/11/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/04/2005 and displayed until 07/11/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/03/2005 and displayed until 18/04/2005
Reasons for adding or updating:
  • Change to Further Information section
Updated on 10/02/2004 and displayed until 10/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 20/08/2001 and displayed until 10/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/07/2001 and displayed until 20/08/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 25/04/2001 and displayed until 09/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   palivizumab